ADMA · Adma Biologics, Inc.
Market Cap
$2.09B
Shares
223.98M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-02 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-05-04 | — | |
| DEF 14A | 2026-04-15 | 2026-06-02 | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-03-02 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | 2026-02-20 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-08-06 | 2025-08-05 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-07 | 2025-05-05 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-04-28 | — | |
| DEF 14A | 2025-04-15 | 2025-06-04 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-21 | 2025-02-19 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-02 | 2024-12-30 | |
| 8-K | 2024-12-20 | — | |
| 8-K | 2024-11-21 | 2024-11-19 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-10-10 | 2024-10-09 | |
| 8-K | 2024-10-09 | 2024-10-03 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-26 | 2024-07-24 | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 8-K | 2024-06-04 | — | |
| 8-K | 2024-05-17 | — | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-15 | 2024-06-04 | |
| 8-K | 2024-04-02 | 2024-04-01 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-03-05 | 2024-03-04 | |
| 8-K | 2024-02-28 | 2024-02-26 | |
| 8-K | 2024-02-28 | — | |
| 10-K | 2024-02-28 | 2023-12-31 |
Showing 1–50 of 157 filings
Key facts
CIK
1368514
CUSIP
000899104
13F (30d)
254 filings
250 filers
Visit website
Investor relations